Media Release - US FDA review for SCENESSE® extended 3 months
Melbourne, Australia 3 June 2019 Download PDF The FDA sets new goal...
Read More
US FDA extends PDUFA date for SCENESSE®
Melbourne, Australia 3 June 2019 Download PDF The FDA sets new goal...
Read More
CLINUVEL Newsletter
02 May 2019 Download PDF Dear patients, shareholders, friends, In this Communiqué...
Read More
Appendix 4C
Melbourne, Australia, 30 April 2019 Download PDF CLINUVEL PHARMACEUTICALS LTD, a global...
Read More
Chair Letter to Shareholders
24 April 2019 Download PDF Dear All, On a continent where very...
Read More
Presentation Goldman Sachs Emerging Leaders Conference
04 April 2019 Download PDF to view presentation
Read More
CLINUVEL Hosts European EPP Clinical Expert Meetings
Melbourne, Australia and Leatherhead, UK, 29 March 2019 Download PDF to read...
Read More
CLINUVEL Newsletter – March 2019
20 March 2019 Download PDF Dear patients, shareholders, friends,In the third Communiqué...
Read More
UK NICE Meeting Held
Melbourne, Australia, 15 March 2019 Third meeting of Highly Specialised Technology Committee...
Read More
Change in substantial holding
13 March 2019 Form 604Corporations Act 2001Section 671BNotice of change of interests...
Read More
Change in substantial holding
13 March 2019 Form 604Corporations Act 2001Section 671BNotice of change of interests...
Read More
Change of Director’s Interest Notice x 3
13 March 2019 Change of Director’s Interest Notice Download PDF to read...
Read More
Appendix 3B
13 March 2019 New issue announcement, application for quotation of additional securities...
Read More